Caricamento...
Adverse events in a newborn on valproate therapy due to loss-of-function mutations in CYP2C9
An increased risk of valproate-induced toxicity has been reported in children, particularly in those younger than 2 years of age. Significant variations in valproate pharmacokinetics and shifts in the metabolic pathways towards CYP2C9-dependent metabolism seem to play some role in the age-related di...
Salvato in:
| Pubblicato in: | Epilepsy Behav Case Rep |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4588450/ https://ncbi.nlm.nih.gov/pubmed/26543813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebcr.2015.08.006 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|